Clinical Laserthermia Systems AB (publ) (STO:CLS.B)
Sweden · Delayed Price · Currency is SEK 1.848
-0.030 (-1.60%)
Aug 14, 2026, 4:35 PM CET
STO:CLS.B Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 12.56 | 17.49 | 18.78 | 8.27 | 6.27 | 2.25 |
Other Revenue | - | - | -0 | 0 | - | - |
| 12.56 | 17.49 | 18.78 | 8.27 | 6.27 | 2.25 | |
Revenue Growth | -47.42% | -6.90% | 127.03% | 31.99% | 179.20% | 68.54% |
Cost of Revenue | 5.58 | 6.57 | 8.36 | 5.28 | 9.06 | 5.88 |
Gross Profit | 6.98 | 10.92 | 10.42 | 3 | -2.79 | -3.63 |
Selling, General & Admin | 38.9 | 37.33 | 62.04 | 66.13 | 62.29 | 54.2 |
Other Operating Expenses | 0.33 | 0.19 | -0.06 | -0.36 | -0.09 | -0 |
Operating Expenses | 41.88 | 40.11 | 64.65 | 68.48 | 64.65 | 56.98 |
Operating Income | -34.9 | -29.19 | -54.23 | -65.48 | -67.44 | -60.61 |
Interest Expense | -0.11 | -0.09 | -0.43 | -9.76 | -10.97 | -6.41 |
Interest & Investment Income | 3.73 | - | 6.83 | 0.3 | 7.4 | 2.91 |
Currency Exchange Gain (Loss) | - | - | -0.02 | -0.45 | -0 | -0.07 |
Other Non Operating Income (Expenses) | -6.36 | 0.24 | -0 | -0 | -0.22 | 0.03 |
EBT Excluding Unusual Items | -37.64 | -29.04 | -47.86 | -75.39 | -71.24 | -64.14 |
Gain (Loss) on Sale of Investments | -2.29 | -13 | - | -5.48 | -0.03 | - |
Pretax Income | -39.92 | -42.05 | -47.86 | -80.88 | -71.27 | -64.14 |
Earnings From Continuing Operations | -39.92 | -42.05 | -47.86 | -80.88 | -71.27 | -64.14 |
Minority Interest in Earnings | 0.43 | 0.43 | 0.24 | 1.08 | 0.61 | 0.53 |
Net Income | -39.5 | -41.61 | -47.62 | -79.79 | -70.66 | -63.62 |
Net Income to Common | -39.5 | -41.61 | -47.62 | -79.79 | -70.66 | -63.62 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 30 | 26 | 11 | 3 | 0 | 0 |
Shares Outstanding (Diluted) | 30 | 26 | 11 | 3 | 0 | 0 |
Shares Change | 56.44% | 134.96% | 227.83% | 705.35% | 45.02% | 30.24% |
EPS (Basic) | -1.31 | -1.61 | -4.32 | -23.76 | -169.43 | -221.20 |
EPS (Diluted) | -1.31 | -1.61 | -4.32 | -23.76 | -169.43 | -221.20 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -32.35 | -35.91 | -63.93 | -68.6 | -82.1 | -66.32 |
Free Cash Flow Per Share | -1.07 | -1.39 | -5.81 | -20.42 | -196.85 | -230.61 |
Gross Margin | 55.56% | 62.44% | 55.47% | 36.23% | -44.51% | -161.69% |
Operating Margin | -277.95% | -166.90% | -288.72% | -791.47% | -1075.95% | -2699.97% |
Profit Margin | -314.55% | -237.96% | -253.54% | -964.46% | -1127.31% | -2833.63% |
Free Cash Flow Margin | -257.62% | -205.33% | -340.34% | -829.16% | -1309.76% | -2954.16% |
EBITDA | -32.25 | -26.6 | -53.93 | -65.14 | -67.05 | -59.93 |
EBITDA Margin | -256.86% | -152.12% | -287.10% | - | - | - |
D&A For EBITDA | 2.65 | 2.58 | 0.3 | 0.34 | 0.39 | 0.68 |
EBIT | -34.9 | -29.19 | -54.23 | -65.48 | -67.44 | -60.61 |
EBIT Margin | -277.95% | -166.90% | -288.72% | - | - | - |
Revenue as Reported | - | - | - | - | - | 2.41 |